Wells David R. has filed 4 insider transactions across 2 companies since October 2023.
Most recent transaction: a grant/award of 15000 shares of HeartSciences Inc. ($HSCS) on January 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | HeartSciences Inc. | $HSCS | Wells David R. | Director | A | Restricted Stock Units | 15000 | $0.00 | 15,000.0000 | 3,178,207 | 9999.99% | 0.47% |
| July 9, 2025 | HeartSciences Inc. | $HSCS | Wells David R. | Director | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2025 | HeartSciences Inc. | $HSCS | Wells David R. | Director | A | Employee Stock Option (Right to Buy) | 6000 | $0.00 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2023 | Envoy Medical, Inc. | $COCH | Wells David R. | Chief Financial Officer | A | Stock Option (right to buy) | 293250 | $0.00 | 293,250.0000 | 11,215,068 | 9999.99% | 2.61% |